Trial
NCT03051945
Endogenous Opioid Modulation by Ketamine
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Utah
Collaborators
—
Condition
Major Depressive Disorder
Intervention
Ketamine Hydrochloride
Why stopped
Unable to perform brain imaging
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-28